Smarten Power Systems Fund Raise of ₹40.01 Cr

Smarten Power Systems Board Meeting Date

Smarten Power Systems will hold a board meeting on 2 November 2026 to consider unaudited half-yearly financial results. The trading window is closed from 1 to 4 October 2026.

Smarten Power Systems Business Update

Smarten Power Systems sold 1.07 lakh units in Q2 FY27, added 22 distributors, and launched 7 new products. Production recorded 47,919 units for the quarter.

Smarten Power Systems Other Announcement

Smarten Power Systems Limited shareholders approved the appointment of M/s CSA & Associates as Secretarial Auditors. The firm will serve a five-year term until the 17th AGM.

Execution

5 consecutive financial years

Smarten Power Systems Annual General Meeting

Smarten Power Systems held its 12th Annual General Meeting on September 24, 2026. The meeting covered agenda items including the adoption of financial statements and director appointments.

Smarten Power Systems Product Launch

Smarten Power Systems unveiled 7 new solar and power-backup products at REV Expo Lucknow 2026. The launch spans hybrid, on-grid and UPS applications for residential and commercial use.

Smarten Power Systems Other Announcement

Smarten Power Systems Limited has appointed Adfactors PR Private Limited as its Investor Relations agency. The appointment for advisory services is effective from September 03, 2026.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr